Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$42.97 - $60.6 $635,956 - $896,880
14,800 New
14,800 $647 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.71B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Sig Brokerage, LP Portfolio

Follow Sig Brokerage, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sig Brokerage, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sig Brokerage, LP with notifications on news.